Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMonitise Regulatory News (MONI)

  • There is currently no data for MONI

Total Voting Rights

1 Jun 2016 09:00

RNS Number : 7885Z
Monitise PLC
01 June 2016
 

01 June 2016

Monitise plc

(The "Company")

 

Total Voting Rights

 

As at 31 May 2016 the Company's issued share capital consisted of 2,251,943,013 ordinary shares of 1p each. The Company holds no ordinary shares in Treasury.

 

The total number of voting rights in the Company is therefore 2,251,943,013. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

About Monitise

 

Monitise plc (LSE: MONI) is a leader in enabling accelerated digital innovation within industries where security, compliance and scalability are mandated. Our platforms, toolkits, products and ideas draw upon over a decade of experience of building and operating world class digital banking, and support all stages of a digital solution from strategy to concept design, development and operations. Find out more at www.monitise.com.

 

Contacts:

 

Monitise plc

Tom Spurgeon, Company Secretary

Tel: +44(0)20 3657 0900

Canaccord Genuity Limited (NOMAD)

Simon Bridges, Cameron Duncan, Emma Gabriel

Tel: +44(0)20 7523 8000

Brunswick

Jonathan Glass

Tel: +44 (0)20 7404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUAOVRNAAVOAR
Date   Source Headline
8th Jun 20179:00 amRNSBlock listing Return
1st Jun 20179:00 amRNSTotal Voting Rights
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension
2nd May 20179:00 amRNSTotal Voting Rights
21st Apr 20178:31 amRNSHolding(s) in Company
3rd Apr 20179:00 amRNSTotal Voting Rights
1st Mar 20179:00 amRNSTotal Voting Rights
24th Feb 20177:00 amRNSIssue of Deferred Consideration
23rd Feb 20177:00 amRNSHalf-year Report
1st Feb 20179:22 amRNSTotal Voting Rights
12th Jan 201711:24 amRNSNotice of Results
3rd Jan 201711:56 amRNSStatement re Monitise Americas
3rd Jan 20179:00 amRNSTotal Voting Rights
30th Dec 201612:35 pmRNSPrice Monitoring Extension
28th Dec 20169:59 amRNSBlock listing Return
8th Dec 20169:00 amRNSBlock listing Return
1st Dec 20168:59 amRNSTotal Voting Rights
24th Nov 20164:35 pmRNSPrice Monitoring Extension
1st Nov 20169:39 amRNSTotal Voting Rights
19th Oct 20161:09 pmRNSResult of AGM
14th Oct 20163:46 pmRNSHolding(s) in Company
3rd Oct 20169:00 amRNSTotal Voting Rights
20th Sep 20169:00 amRNSAnnual Report & Accounts and Notice of AGM
8th Sep 20167:00 amRNSFY 2016 Results
7th Sep 20164:53 pmRNSChange of Registered Office
1st Sep 20166:24 pmRNSTotal Voting Rights
21st Jul 20167:00 amRNSTrading Update
7th Jul 20164:38 pmRNSHolding(s) in Company
7th Jul 20161:07 pmRNSIssue of Deferred Consideration
1st Jul 20164:45 pmRNSTotal Voting Rights
30th Jun 20166:25 pmRNSDirectorate Change
27th Jun 20169:00 amRNSBlock Listing Return
24th Jun 201612:08 pmRNSSecond Price Monitoring Extn
24th Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 201612:07 pmRNSSecond Price Monitoring Extn
16th Jun 201612:02 pmRNSPrice Monitoring Extension
15th Jun 201612:07 pmRNSSecond Price Monitoring Extn
15th Jun 201612:02 pmRNSPrice Monitoring Extension
14th Jun 201612:07 pmRNSSecond Price Monitoring Extn
14th Jun 201612:02 pmRNSPrice Monitoring Extension
8th Jun 20169:00 amRNSBlock Listing Return
1st Jun 20164:40 pmRNSSecond Price Monitoring Extn
1st Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20169:00 amRNSTotal Voting Rights
31st May 20167:00 amRNSStatement re Monitise Content
3rd May 20169:00 amRNSTotal Voting Rights
1st Apr 20169:00 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSAppointment of COO
17th Mar 20164:13 pmRNSIssue of earn-out consideration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.